Suppr超能文献

CDK8模块亚基对……中细胞生长和增殖的不同影响

Distinct effects of CDK8 module subunits on cellular growth and proliferation in .

作者信息

Li Xiao, Liu Mengmeng, Xing Yue, Niu Ye, Liu Tzu-Hao, Sun Jasmine L, Liu Yanwu, Hemba-Waduge Rajitha-Udakara-Sampath, Ji Jun-Yuan

出版信息

bioRxiv. 2024 May 3:2024.04.30.591924. doi: 10.1101/2024.04.30.591924.

Abstract

UNLABELLED

The Mediator complex, composed of about 30 conserved subunits, plays a pivotal role in facilitating RNA polymerase II-dependent transcription in eukaryotes. Within this complex, the CDK8 kinase module (CKM), comprising Med12, Med13, CDK8, and CycC (Cyclin C), serves as a dissociable subcomplex that modulates the activity of the small Mediator complex. Genetic studies in have revealed distinct phenotypes of CDK8-CycC and Med12-Med13 mutations, yet the underlying mechanism has remained unknown. Here, using as a model organism, we show that depleting CDK8-CycC enhances E2F1 target gene expression and promotes cell-cycle progression. Conversely, depletion of Med12-Med13 affects the expression of ribosomal protein genes and fibrillarin, indicating a more severe reduction in ribosome biogenesis and cellular growth compared to the loss of CDK8-CycC. Moreover, we found that the stability of CDK8 and CycC relies on Med12 and Med13, with a mutually interdependent relationship between Med12 and Med13. Furthermore, CycC stability depends on the other three CKM subunits. These findings reveal distinct roles for CKM subunits , with Med12-Med13 disruption exerting a more pronounced impact on ribosome biogenesis and cellular growth compared to the loss of CDK8-CycC.

SIGNIFICANCE

The CDK8 kinase module (CKM), comprising CDK8, CycC, Med12, and Med13, is essential in the Mediator complex for RNA polymerase II-dependent transcription in eukaryotes. While expected to function jointly, CKM subunit mutations result in distinct phenotypes in . This study investigates the mechanisms driving these differing effects. Our analysis reveals the role of Med12-Med13 pair in regulating ribosomal biogenesis and cellular growth, contrasting with the involvement of CDK8-CycC in E2F1-dependent cell-cycle progression. Additionally, an asymmetric interdependence in the stability of CDK8-CycC and Med12-Med13 was observed. CKM mutations or overexpression are associated with cancers and cardiovascular diseases. Our findings underscore the distinct impacts of CKM mutations on cellular growth and proliferation, advancing our understanding of their diverse consequences .

摘要

未标注

中介体复合物由约30个保守亚基组成,在促进真核生物中依赖RNA聚合酶II的转录过程中起关键作用。在这个复合物中,CDK8激酶模块(CKM)由Med12、Med13、CDK8和CycC(细胞周期蛋白C)组成,作为一个可解离的亚复合物,调节小中介体复合物的活性。此前的遗传学研究揭示了CDK8 - CycC和Med12 - Med13突变的不同表型,但其潜在机制仍不清楚。在这里,我们以[未提及的某种生物]为模式生物,表明去除CDK8 - CycC可增强E2F1靶基因的表达并促进细胞周期进程。相反,去除Med12 - Med13会影响核糖体蛋白基因和纤维蛋白原的表达,这表明与CDK8 - CycC缺失相比,核糖体生物合成和细胞生长的减少更为严重。此外,我们发现CDK8和CycC的稳定性依赖于Med12和Med13,且Med12和Med13之间存在相互依存关系。此外,CycC的稳定性还依赖于其他三个CKM亚基。这些发现揭示了CKM亚基的不同作用,与CDK8 - CycC缺失相比,Med12 - Med13的破坏对核糖体生物合成和细胞生长的影响更为显著。

意义

由CDK8、CycC、Med12和Med13组成的CDK8激酶模块(CKM)在中介体复合物中对真核生物中依赖RNA聚合酶II的转录至关重要。虽然预期它们共同发挥作用,但CKM亚基突变在[未提及的某种生物]中会导致不同的表型。本研究调查了导致这些不同效应的机制。我们的分析揭示了Med12 - Med13对在调节核糖体生物合成和细胞生长中的作用,这与CDK8 - CycC参与E2F1依赖的细胞周期进程形成对比。此外,还观察到CDK8 - CycC和Med12 - Med13稳定性的不对称相互依存关系。CKM突变或过表达与癌症和心血管疾病有关。我们的发现强调了CKM突变对细胞生长和增殖的不同影响,增进了我们对其多样后果的理解。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验